Cargando…

Targeting Pim kinases in hematological cancers: molecular and clinical review

Decades of research has recognized a solid role for Pim kinases in lymphoproliferative disorders. Often up-regulated following JAK/STAT and tyrosine kinase receptor signaling, Pim kinases regulate cell proliferation, survival, metabolism, cellular trafficking and signaling. Targeting Pim kinases rep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bellon, Marcia, Nicot, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875428/ https://www.ncbi.nlm.nih.gov/pubmed/36694243 http://dx.doi.org/10.1186/s12943-023-01721-1

Ejemplares similares

PIM Kinase as an Executional Target in Cancer
por: Zhang, Xinning, et al.
Publicado: (2018)

Telomere Dynamics in Immune Senescence and Exhaustion Triggered by Chronic Viral Infection
por: Bellon, Marcia, et al.
Publicado: (2017)

Targeting the Pim kinases in multiple myeloma
por: Keane, N A, et al.
Publicado: (2015)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

FBXW7: a critical tumor suppressor of human cancers
por: Yeh, Chien-Hung, et al.
Publicado: (2018)

Targeting PIM Kinases to Improve the Efficacy of Immunotherapy
por: Clements, Amber N., et al.
Publicado: (2022)

STAT1: A Novel Target of miR-150 and miR-223 Is Involved in the Proliferation of HTLV-I–Transformed and ATL Cells()
por: Moles, Ramona, et al.
Publicado: (2015)

An overview of pim kinase as a target in multiple myeloma
por: Liu, Zhaoyun, et al.
Publicado: (2023)

Protein kinase PIM2: A simple PIM family kinase with complex functions in cancer metabolism and therapeutics
por: Wang, Yixin, et al.
Publicado: (2021)

Clinical significance of FBXW7 loss of function in human cancers
por: Fan, Jingyi, et al.
Publicado: (2022)

PIM Kinases in Multiple Myeloma
por: Wu, Jian, et al.
Publicado: (2021)

FHIT as a biomarker for early screening of adult T-cell leukemia
por: Bellon, Marcia, et al.
Publicado: (2021)

PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer
por: Luszczak, Sabina, et al.
Publicado: (2020)

A review on PIM kinases in tumors
por: Arrouchi, Housna, et al.
Publicado: (2019)

Pim Kinases: Important Regulators of Cardiovascular Disease
por: Nock, Sophie, et al.
Publicado: (2023)

The Role of PIM Kinases in Pediatric Solid Tumors
por: Julson, Janet Rae, et al.
Publicado: (2022)

PIM kinases as therapeutic targets against advanced melanoma
por: Shannan, Batool, et al.
Publicado: (2016)

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
por: Stafman, Laura L., et al.
Publicado: (2018)

Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance
por: Chauhan, Shailender S., et al.
Publicado: (2018)

The role of PIM1/PIM2 kinases in tumors of the male reproductive system
por: Jiménez-García, Manuel Pedro, et al.
Publicado: (2016)

Re-positioning of known drugs for Pim-1 kinase target using molecular docking analysis
por: Arrouchi, Housna, et al.
Publicado: (2019)

PIM-1 kinase: a potential biomarker of triple-negative breast cancer
por: Chen, Jieying, et al.
Publicado: (2019)

Expression and ERG regulation of PIM kinases in prostate cancer
por: Eerola, Sini K., et al.
Publicado: (2021)

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma
por: Mahalingam, D, et al.
Publicado: (2011)

Targeting Host PIM Protein Kinases Reduces Mayaro Virus Replication
por: Sugasti-Salazar, Madelaine, et al.
Publicado: (2022)

Targeting Echinococcus multilocularis PIM kinase for improving anti-parasitic chemotherapy
por: Koike, Akito, et al.
Publicado: (2022)

The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
por: Forshell, Linus Plym, et al.
Publicado: (2011)

Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion
por: Santio, Niina M, et al.
Publicado: (2010)

Targeting Casein Kinase 1 (CK1) in Hematological Cancers
por: Janovská, Pavlína, et al.
Publicado: (2020)

[Retracted] Expression and function of PIM kinases in osteosarcoma
por: Mou, Shuai, et al.
Publicado: (2023)

Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC
por: Moore, Gillian, et al.
Publicado: (2021)

JAG1 overexpression contributes to Notch1 signaling and the migration of HTLV-1-transformed ATL cells
por: Bellon, Marcia, et al.
Publicado: (2018)

Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus
por: Jiménez-García, Manuel-Pedro, et al.
Publicado: (2017)

Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
por: Wang, Jie, et al.
Publicado: (2010)

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer
por: Aziz, Aziz Ur Rehman, et al.
Publicado: (2018)

Pim Kinases Promote Migration and Metastatic Growth of Prostate Cancer Xenografts
por: Santio, Niina M., et al.
Publicado: (2015)

PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
por: Marayati, Raoud, et al.
Publicado: (2021)

Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies
por: Koblish, Holly, et al.
Publicado: (2018)

The PIM family of oncoproteins: Small kinases with huge implications in myeloid leukemogenesis and as therapeutic targets
por: Saurabh, Kumar, et al.
Publicado: (2014)

PIM Kinases as Potential Therapeutic Targets in a Subset of Peripheral T Cell Lymphoma Cases
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_uh8biafbo4djrp0llr9q04ek0q